vs
IAC Inc.（IAC）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
IAC Inc.的季度营收约是Royalty Pharma plc的1.0倍（$646.0M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs -11.9%，领先46.3%），Royalty Pharma plc同比增速更快（4.8% vs -10.5%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs 1.7%）
IAC Inc.是一家美国控股企业，业务覆盖媒体与互联网领域，在全球拥有多个知名品牌。公司前身是1996年成立的HSN Inc.，当时作为家庭购物频道Home Shopping Network和USA电视台的控股主体运营，1999年更名为USA Networks Inc.，2002年将旗下电视业务资产出售给威望迪集团。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
IAC vs RPRX — 直观对比
营收规模更大
IAC
是对方的1.0倍
$622.0M
营收增速更快
RPRX
高出15.2%
-10.5%
净利率更高
RPRX
高出46.3%
-11.9%
两年增速更快
RPRX
近两年复合增速
1.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $646.0M | $622.0M |
| 净利润 | $-76.8M | $214.2M |
| 毛利率 | 69.8% | — |
| 营业利润率 | -17.5% | 62.4% |
| 净利率 | -11.9% | 34.4% |
| 营收同比 | -10.5% | 4.8% |
| 净利润同比 | 61.4% | 2.9% |
| 每股收益（稀释后） | $-0.96 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IACRPRX
| Q4 25 | $646.0M | $622.0M | ||
| Q3 25 | $589.8M | $609.3M | ||
| Q2 25 | $586.9M | $578.7M | ||
| Q1 25 | $570.5M | $568.2M | ||
| Q4 24 | $721.4M | $593.6M | ||
| Q3 24 | $642.0M | $564.7M | ||
| Q2 24 | $634.4M | $537.3M | ||
| Q1 24 | $624.3M | $568.0M |
净利润IACRPRX
| Q4 25 | $-76.8M | $214.2M | ||
| Q3 25 | $-21.9M | $288.2M | ||
| Q2 25 | $211.5M | $30.2M | ||
| Q1 25 | $-216.8M | $238.3M | ||
| Q4 24 | $-199.0M | $208.2M | ||
| Q3 24 | $-243.7M | $544.0M | ||
| Q2 24 | $-142.2M | $102.0M | ||
| Q1 24 | $45.0M | $4.8M |
毛利率IACRPRX
| Q4 25 | 69.8% | — | ||
| Q3 25 | 64.8% | — | ||
| Q2 25 | 65.6% | — | ||
| Q1 25 | 64.0% | — | ||
| Q4 24 | 65.8% | — | ||
| Q3 24 | 62.1% | — | ||
| Q2 24 | 60.1% | — | ||
| Q1 24 | 58.4% | — |
营业利润率IACRPRX
| Q4 25 | -17.5% | 62.4% | ||
| Q3 25 | -3.5% | 70.1% | ||
| Q2 25 | 0.1% | 36.3% | ||
| Q1 25 | 6.3% | 94.0% | ||
| Q4 24 | 6.7% | 60.9% | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | -3.4% | 50.2% | ||
| Q1 24 | -10.2% | -13.0% |
净利率IACRPRX
| Q4 25 | -11.9% | 34.4% | ||
| Q3 25 | -3.7% | 47.3% | ||
| Q2 25 | 36.0% | 5.2% | ||
| Q1 25 | -38.0% | 41.9% | ||
| Q4 24 | -27.6% | 35.1% | ||
| Q3 24 | -38.0% | 96.3% | ||
| Q2 24 | -22.4% | 19.0% | ||
| Q1 24 | 7.2% | 0.8% |
每股收益（稀释后）IACRPRX
| Q4 25 | $-0.96 | $0.49 | ||
| Q3 25 | $-0.27 | $0.67 | ||
| Q2 25 | $2.57 | $0.07 | ||
| Q1 25 | $-2.64 | $0.55 | ||
| Q4 24 | $-2.36 | $0.46 | ||
| Q3 24 | $-2.93 | $1.21 | ||
| Q2 24 | $-1.71 | $0.23 | ||
| Q1 24 | $0.51 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $960.2M | $618.7M |
| 总债务越低越好 | $1.4B | $9.0B |
| 股东权益账面价值 | $4.7B | $9.7B |
| 总资产 | $7.1B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.30× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资IACRPRX
| Q4 25 | $960.2M | $618.7M | ||
| Q3 25 | $1.0B | $938.9M | ||
| Q2 25 | $1.1B | $631.9M | ||
| Q1 25 | $1.2B | $1.1B | ||
| Q4 24 | $1.4B | $929.0M | ||
| Q3 24 | $1.3B | $950.1M | ||
| Q2 24 | $1.3B | $1.8B | ||
| Q1 24 | $1.3B | $843.0M |
总债务IACRPRX
| Q4 25 | $1.4B | $9.0B | ||
| Q3 25 | $1.4B | $8.9B | ||
| Q2 25 | $1.4B | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益IACRPRX
| Q4 25 | $4.7B | $9.7B | ||
| Q3 25 | $4.8B | $9.6B | ||
| Q2 25 | $4.9B | $9.5B | ||
| Q1 25 | $4.7B | $9.8B | ||
| Q4 24 | $5.6B | $10.3B | ||
| Q3 24 | $5.8B | $10.3B | ||
| Q2 24 | $6.0B | $9.8B | ||
| Q1 24 | $6.1B | $9.9B |
总资产IACRPRX
| Q4 25 | $7.1B | $19.6B | ||
| Q3 25 | $7.2B | $19.3B | ||
| Q2 25 | $7.4B | $18.3B | ||
| Q1 25 | $7.2B | $17.6B | ||
| Q4 24 | $9.7B | $18.2B | ||
| Q3 24 | $9.8B | $18.0B | ||
| Q2 24 | $10.2B | $17.7B | ||
| Q1 24 | $10.4B | $16.1B |
负债/权益比IACRPRX
| Q4 25 | 0.30× | 0.92× | ||
| Q3 25 | 0.30× | 0.93× | ||
| Q2 25 | 0.30× | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $36.6M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $31.4M | — |
| 自由现金流率自由现金流/营收 | 4.9% | — |
| 资本支出强度资本支出/营收 | 0.8% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | $44.8M | — |
8季度趋势，按日历期对齐
经营现金流IACRPRX
| Q4 25 | $36.6M | $827.1M | ||
| Q3 25 | $30.1M | $702.6M | ||
| Q2 25 | $-2.8M | $364.0M | ||
| Q1 25 | $63.0K | $596.1M | ||
| Q4 24 | $110.1M | $742.5M | ||
| Q3 24 | $95.3M | $703.6M | ||
| Q2 24 | $85.0M | $658.2M | ||
| Q1 24 | $64.1M | $664.6M |
自由现金流IACRPRX
| Q4 25 | $31.4M | — | ||
| Q3 25 | $25.3M | — | ||
| Q2 25 | $-7.2M | — | ||
| Q1 25 | $-4.6M | — | ||
| Q4 24 | $104.8M | — | ||
| Q3 24 | $92.0M | — | ||
| Q2 24 | $81.6M | — | ||
| Q1 24 | $61.1M | — |
自由现金流率IACRPRX
| Q4 25 | 4.9% | — | ||
| Q3 25 | 4.3% | — | ||
| Q2 25 | -1.2% | — | ||
| Q1 25 | -0.8% | — | ||
| Q4 24 | 14.5% | — | ||
| Q3 24 | 14.3% | — | ||
| Q2 24 | 12.9% | — | ||
| Q1 24 | 9.8% | — |
资本支出强度IACRPRX
| Q4 25 | 0.8% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 0.8% | — | ||
| Q4 24 | 0.7% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.5% | — | ||
| Q1 24 | 0.5% | — |
现金转化率IACRPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | -0.01× | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | 1.42× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IAC
| $168.5M | 26% | |
| Performance Marketing | $101.2M | 16% |
| Care.com | $85.7M | 13% |
| Subscription | $69.5M | 11% |
| Licensing And Other | $43.8M | 7% |
| Consumer Revenue | $43.2M | 7% |
| Advertising | $35.9M | 6% |
| Project And Other Print | $33.6M | 5% |
| Advertising Google | $28.9M | 4% |
| Newsstand | $22.4M | 3% |
| Emerging Other | $19.6M | 3% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
